These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21377430)

  • 1. Comparison of plasma and dry blood spots as samples for the determination of nitisinone (NTBC) by high-performance liquid chromatography-tandem mass spectrometry. Study of the stability of the samples at different temperatures.
    Prieto JA; Andrade F; Lage S; Aldámiz-Echevarría L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Apr; 879(11-12):671-6. PubMed ID: 21377430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simple and fast quantification of nitisone (NTBC) using liquid chromatography-tandem mass spectrometry method in plasma of tyrosinemia type 1 patients.
    Davit-Spraul A; Romdhane H; Poggi-Bach J
    J Chromatogr Sci; 2012 May; 50(5):446-9. PubMed ID: 22511487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid chromatography tandem mass spectrometry method for the quantitation of NTBC (2-(nitro-4-trifluoromethylbenzoyl)1,3-cyclohexanedione) in plasma of tyrosinemia type 1 patients.
    Herebian D; Spiekerkötter U; Lamshöft M; Thimm E; Laryea M; Mayatepek E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 May; 877(14-15):1453-9. PubMed ID: 19345648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LC-MS/MS method for simultaneous determination on a dried blood spot of multiple analytes relevant for treatment monitoring in patients with tyrosinemia type I.
    la Marca G; Malvagia S; Materazzi S; Della Bona ML; Boenzi S; Martinelli D; Dionisi-Vici C
    Anal Chem; 2012 Jan; 84(2):1184-8. PubMed ID: 22148291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of NTBC in serum samples from patients with hereditary tyrosinemia type I by capillary electrophoresis.
    Cansever MS; Aktuğlu-Zeybek AC; Erim FB
    Talanta; 2010 Mar; 80(5):1846-8. PubMed ID: 20152421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring tyrosinaemia type I: Blood spot test for nitisinone (NTBC).
    Sander J; Janzen N; Terhardt M; Sander S; Gökcay G; Demirkol M; Ozer I; Peter M; Das AM
    Clin Chim Acta; 2011 Jan; 412(1-2):134-8. PubMed ID: 20883679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of the HIV-integrase inhibitor raltegravir and detection of its main metabolite in human plasma, dried blood spots and peripheral blood mononuclear cell lysate by means of high-performance liquid chromatography tandem mass spectrometry.
    Ter Heine R; Hillebrand MJ; Rosing H; van Gorp EC; Mulder JW; Beijnen JH; Huitema AD
    J Pharm Biomed Anal; 2009 Feb; 49(2):451-8. PubMed ID: 19128911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione in plasma by direct injection into a coupled column liquid chromatographic system.
    Bielenstein M; Astner L; Ekberg S
    J Chromatogr B Biomed Sci Appl; 1999 Jul; 730(2):177-82. PubMed ID: 10448952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of NTBC metabolites in urine from patients with hereditary tyrosinemia type 1 using two different mass spectrometric platforms: triple stage quadrupole and LTQ-Orbitrap.
    Herebian D; Lamshöft M; Mayatepek E; Spiekerkoetter U
    Rapid Commun Mass Spectrom; 2010 Mar; 24(6):791-800. PubMed ID: 20187082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous measurement of cyclosporin A and tacrolimus from dried blood spots by ultra high performance liquid chromatography tandem mass spectrometry.
    Hinchliffe E; Adaway JE; Keevil BG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb; 883-884():102-7. PubMed ID: 21680259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of NTBC (2-(2-nitro-4-fluoromethylbenzoyl)-1,3-cyclohexanedione) and mesotrione, inhibitors of 4-hydroxyphenyl pyruvate dioxygenase (HPPD) following a single dose to healthy male volunteers.
    Hall MG; Wilks MF; Provan WM; Eksborg S; Lumholtz B
    Br J Clin Pharmacol; 2001 Aug; 52(2):169-77. PubMed ID: 11488774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On-line liquid chromatography/tandem mass spectrometry simultaneous determination of opiates, cocainics and amphetamines in dried blood spots.
    Saussereau E; Lacroix C; Gaulier JM; Goulle JP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb; 885-886():1-7. PubMed ID: 22281234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of etravirine (TMC125) in plasma, dried blood spots and peripheral blood mononuclear cell lysate by liquid chromatography tandem mass spectrometry.
    Ter Heine R; Rosing H; van Gorp EC; Mulder JW; Beijnen JH; Huitema AD
    J Pharm Biomed Anal; 2009 Feb; 49(2):393-400. PubMed ID: 19059744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative determination of zidovudine diaryl phosphate triester pro-drugs in rat plasma by high-performance liquid chromatography-electrospray ionization tandem mass spectrometry.
    Zhu M; Xie B; Tang G; Hu A; Fang M; Wu Z; Zhao Y
    J Pharm Biomed Anal; 2008 Dec; 48(5):1417-24. PubMed ID: 19118970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of plasma 5-hydroxyindole acetic acid by liquid chromatography tandem mass spectrometry--comparison with HPLC methodology.
    Miller AG; Brown H; Degg T; Allen K; Keevil BG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Mar; 878(7-8):695-9. PubMed ID: 20117968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Application of succinylacetone levels measurement in the blood and urine in the diagnosis of tyrosinemia type 1].
    Han LS; Ye J; Qiu WJ; Zhang HW; Wang Y; Ji WJ; Gao XL; Li XY; Jin J; Gu XF
    Zhonghua Er Ke Za Zhi; 2012 Feb; 50(2):126-30. PubMed ID: 22455637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved method to determine succinylacetone in dried blood spots for diagnosis of tyrosinemia type 1 using UPLC-MS/MS.
    Al-Dirbashi OY; Rashed MS; Jacob M; Al-Ahaideb LY; Al-Amoudi M; Rahbeeni Z; Al-Sayed MM; Al-Hassnan Z; Al-Owain M; Al-Zeidan H
    Biomed Chromatogr; 2008 Nov; 22(11):1181-5. PubMed ID: 18651606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of moxifloxacin in dried blood spots using LC-MS/MS and the impact of the hematocrit and blood volume.
    Vu DH; Koster RA; Alffenaar JW; Brouwers JR; Uges DR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 May; 879(15-16):1063-70. PubMed ID: 21459055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic drug monitoring of everolimus using the dried blood spot method in combination with liquid chromatography-mass spectrometry.
    van der Heijden J; de Beer Y; Hoogtanders K; Christiaans M; de Jong GJ; Neef C; Stolk L
    J Pharm Biomed Anal; 2009 Nov; 50(4):664-70. PubMed ID: 19155152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simplified method for busulfan monitoring using dried blood spot in combination with liquid chromatography/tandem mass spectrometry.
    Ansari M; Uppugunduri CR; Déglon J; Théorêt Y; Versace F; Gumy-Pause F; Ozsahin H; Dayer P; Desmules J; Daali Y
    Rapid Commun Mass Spectrom; 2012 Jun; 26(12):1437-46. PubMed ID: 22592987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.